Medtronic (MDT 0.12%), one of the largest medical-device players on the planet, reported its fourth-quarter earnings today, and investors were clearly pleased with the results. Shares were up 4.9% by the market close, and this stock is up more than 30% over the past 12 months. But which segments drove the company's business in Q4? How did Medtronic's results measure up against its medical-device peers, like Boston Scientific (BSX 0.68%) and St. Jude Medical (STJ)? Health-care analyst Max Macaluso discusses these topics in the following video.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
What's Behind Medtronic's 5% Pop?
NYSE: MDT
Medtronic

Fourth-quarter results impressed investors today.
Max Macaluso, Ph.D., has no position in any stocks mentioned. The Motley Fool owns shares of Medtronic. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned



*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.